3 studies found for:    23415775 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Ranibizumab
2 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg;   Drug: Sham injection
3 Completed
Has Results
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Sham injection;   Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg

Indicates status has not been verified in more than two years